Nalaganje...
How I manage frontline transplant-eligible multiple myeloma in Italy
The treatment of transplant-eligible multiple myeloma patients in Italy consists in an induction phase based on bortezomib plus thalidomide plus dexamethasone (VTd), followed by a single or tandem autologous stem cell transplantation (ASCT), followed by lenalidomide maintenance. This approach offers...
Shranjeno v:
| izdano v: | Hematol Rep |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
PAGEPress Publications, Pavia, Italy
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7520856/ https://ncbi.nlm.nih.gov/pubmed/33042503 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2020.8954 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|